RAC
Click for more information
1.11% $1.83 race oncology ltd

Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-84

  1. Davisite
    18,984 Posts.
    lightbulb Created with Sketch. 5728
    clock Created with Sketch.
    07/11/23
    12:56
    Post #: 70765936
    This was a Phase 2 trial. What is impressive about this trial is seeing positive results in such a high percentage of very heavily pre-treated AML patients. You don't fail 4 or more lines of therapy in AML and have a high chance of responding to any treatment.
    RAC Price at posting: $1.03 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 38  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83 		Change
0.020(1.11%) 		Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.